In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction

C. Minville, M.N. Hilleret, R. Tamisier, P. Levy, J.P. Zarski, J.L. Pepin (Quebec, Canada; Grenoble, France)

Source: Annual Congress 2012 - Sleep disorders in internal medicine
Session: Sleep disorders in internal medicine
Session type: Poster Discussion
Number: 1882
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Minville, M.N. Hilleret, R. Tamisier, P. Levy, J.P. Zarski, J.L. Pepin (Quebec, Canada; Grenoble, France). In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction. Eur Respir J 2012; 40: Suppl. 56, 1882

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities
Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
Year: 2018



The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Relationship between OSA and non-alcoholic fatty liver disease
Source: ERS Conference
Year: 2015

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011


Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017



Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016


Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Adipose tissue in obesity and obstructive sleep apnoea
Source: Eur Respir J 2012; 39: 746-767
Year: 2012



Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease?
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008


Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011


Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013

Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009